Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy.

Brachytherapy has consistently provided a very conformal radiation therapy modality. Over the last two decades this has been associated with significant improvements in imaging for brachytherapy applications (prostate, gynecology), resulting in many positive advances in treatment planning, application techniques and clinical outcome. This is emphasized by the increased use of brachytherapy in Europe with gynecology as continuous basis and prostate and breast as more recently growing fields. Image guidance enables exact knowledge of the applicator together with improved visualization of tumor and target volumes as well as of organs at risk providing the basis for very individualized 3D and 4D treatment planning. In this commentary the most important recent developments in prostate, gynecological and breast brachytherapy are reviewed, with a focus on European recent and current research aiming at the definition of areas for important future research. Moreover the positive impact of GEC-ESTRO recommendations and the highlights of brachytherapy physics are discussed what altogether presents a full overview of modern image guided brachytherapy. An overview is finally provided on past and current international brachytherapy publications focusing on "Radiotherapy and Oncology". These data show tremendous increase in almost all research areas over the last three decades strongly influenced recently by translational research in regard to imaging and technology. In order to provide high level clinical evidence for future brachytherapy practice the strong need for comprehensive prospective clinical research addressing brachytherapy issues is high-lighted.

[1]  L. Blank,et al.  Office hours pulsed brachytherapy boost in breast cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  R. Tarducci,et al.  Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  P. Maingon,et al.  High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients. , 2011, International journal of radiation oncology, biology, physics.

[4]  J. Hammer,et al.  Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. , 1994, Radiology.

[5]  Dan Ash,et al.  The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  M. Gaztañaga,et al.  Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB). , 2011, International journal of radiation oncology, biology, physics.

[7]  J. Battermann,et al.  Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy. , 2011, International journal of radiation oncology, biology, physics.

[8]  H. de Andrade Carvalho,et al.  Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  J. Dimopoulos,et al.  Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  E. van Limbergen,et al.  Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Kari Tanderup,et al.  Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation , 2007, Physics in medicine and biology.

[12]  L. Potters,et al.  Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. , 2005, Brachytherapy.

[13]  J. Dimopoulos,et al.  Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Facundo Ballester,et al.  Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  D. Ash,et al.  Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. Eble,et al.  Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seeds. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Y. Yoshioka,et al.  High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2003, Medical physics.

[19]  Josef Nilsson,et al.  Prostate volume determination: differential volume measurements comparing CT and TRUS. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  B. Asselain,et al.  Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  R. Pötter,et al.  Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Andrew See,et al.  High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial. , 2012, International journal of radiation oncology, biology, physics.

[23]  S. Nag,et al.  Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  A. Dickler,et al.  Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  J. Sylvester,et al.  Outcomes after prostate brachytherapy are even better than predicted , 2012, Cancer.

[26]  T. Kimura,et al.  Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer , 2012, International Journal of Clinical Oncology.

[27]  Larry A DeWerd,et al.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. , 2011, Medical physics.

[28]  J. Coebergh,et al.  A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  P. Bownes,et al.  Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  H. G. van der Poel,et al.  The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  P. Hoskin,et al.  High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. , 2012, International journal of radiation oncology, biology, physics.

[32]  Jean Pouliot,et al.  High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. , 2009, International journal of radiation oncology, biology, physics.

[33]  Masayuki Matsuo,et al.  Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Shafak Aluwini,et al.  HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  Gerry Lowe,et al.  Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  J. Battermann,et al.  Results of permanent prostate brachytherapy, 13 years of experience at a single institution. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  J. Ciezki Brachytherapy for localized prostate cancer. , 2009, Urology.

[38]  Christian Kirisits,et al.  Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  Christian Kirisits,et al.  Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  V. Kouloulias,et al.  Brachytherapy for Prostate Cancer: A Systematic Review , 2009, Advances in urology.

[41]  Benjamin M Yeh,et al.  Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer. , 2008, Brachytherapy.

[42]  Jeremy MG Taylor,et al.  Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[43]  V. Kataja,et al.  Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy--morbidity and outcome results. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  B. Kimmig,et al.  Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  R. Pötter,et al.  Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  P. Hoskin,et al.  I-125 seed planning: an alternative method of urethra definition. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  J. Yarnold,et al.  Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.

[49]  T. Major,et al.  Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[50]  U. Mahantshetty,et al.  Magnetic resonance image-based dose volume parameters and clinical outcome with high dose rate brachytherapy in cervical cancers--a validation of GYN GEC-ESTRO brachytherapy recommendations. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[51]  Kemal Tuncali,et al.  Interventional MRI for oncologic applications. , 2007, Techniques in vascular and interventional radiology.

[52]  D. Ash,et al.  ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[53]  D. Ash,et al.  Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  I. Henríquez,et al.  Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. , 2010, International journal of radiation oncology, biology, physics.

[55]  Liying Zhang,et al.  Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  Stefaan Vynckier,et al.  Optimization of a breast implant in Brachytherapy PDR: validation with Monte Carlo simulation and measurements with TLDs and GafChromic films. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[57]  S. Vanbelle,et al.  Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer? , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  E. Touboul,et al.  Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  Richard Pötter,et al.  Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer , 2010, Acta oncologica.

[60]  E. van Limbergen,et al.  Is this the swan song of endovascular brachytherapy? , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  C. Koning,et al.  Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  György Németh,et al.  Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  K. Bratengeier,et al.  Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  Ludvig Paul Muren,et al.  Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used , 2010, Acta oncologica.

[65]  P. Levendag,et al.  Quality of life of oropharyngeal cancer patients treated with brachytherapy , 2009, Current oncology reports.

[66]  J. Overgaard,et al.  Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[67]  C. Haie-meder,et al.  152 oral DOSIMETRIC AND CLINICAL RESULTS OF A FRENCH PROSPECTIVE STUDY OF 3D BRACHYTHERAPY FOR CERVIX CARCINOMA , 2011 .

[68]  A. E. Saarnak,et al.  A method to improve the dose distribution of interstitial breast implants using geometrically optimized stepping source techniques and dose normalization. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[69]  F. Vicini,et al.  Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[70]  Kawal Rhode,et al.  An analysis of intraoperative versus post-operative dosimetry with CT, CT-MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[71]  M. Moerland,et al.  Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  D. Ash,et al.  Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience. , 2010, International journal of radiation oncology, biology, physics.

[73]  R. Pötter,et al.  Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast. , 2002, Radiology.

[74]  B. Asselain,et al.  Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients. , 2008, International journal of radiation oncology, biology, physics.

[75]  Christian Kirisits,et al.  New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[76]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[77]  Aeilko H. Zwinderman,et al.  68 oral: Meta-Analysis of Survival Curves of 3 Radiotherapy Modalities on Biochemical Control and Overall Survival for the Treatment of Prostate Cancer; a Systematic Review , 2009 .

[78]  A. Henderson,et al.  Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[79]  M. Eble,et al.  Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[80]  D. Ash,et al.  The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[81]  Christian Kirisits,et al.  Direct reconstruction of the Vienna applicator on MR images. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  L. Kestin,et al.  Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate Cancer , 2007 .

[83]  J. Overgaard Advancing radiation oncology through scientific publication--100 volumes of Radiotherapy and Oncology. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[84]  Christine Haie-Meder,et al.  Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. , 2009, International journal of radiation oncology, biology, physics.

[85]  Jan J W Lagendijk,et al.  A new robotic needle insertion method to minimise attendant prostate motion. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[86]  H. G. van der Poel,et al.  An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors. , 2008, Radiotherapy and Oncology.

[87]  Christian Kirisits,et al.  Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. , 2005, International journal of radiation oncology, biology, physics.

[88]  P. Ágoston,et al.  Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. , 2011, Brachytherapy.

[89]  C. Hurkmans,et al.  Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[90]  Marisol De Brabandere,et al.  Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[91]  J. Dimopoulos,et al.  The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. , 2006, International journal of radiation oncology, biology, physics.

[92]  P. Grigsby,et al.  Tumor volume discrepancies between FDG-PET and MRI for cervical cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[93]  J. Dimopoulos,et al.  Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. , 2012, International journal of radiation oncology, biology, physics.

[94]  M. Moerland,et al.  MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[95]  G. Gustafson,et al.  High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer , 2010, American journal of clinical oncology.

[96]  Anna Niwin¯ska,et al.  Cosmetic evaluation of breast conserving treatment for mammary cancer , 1998 .

[97]  Gerhard Jakse,et al.  Rectal dosimetry following prostate brachytherapy with stranded seeds--comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[98]  P. Hoskin,et al.  Brachytherapy in the United Kingdom and Spain: a subset analysis of a European pattern of care survey , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[99]  Sasa Mutic,et al.  Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. , 2007, International journal of radiation oncology, biology, physics.

[100]  Christian Kirisits,et al.  Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[101]  C. Coles,et al.  Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[102]  J. Dimopoulos,et al.  Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[103]  S. Yoon,et al.  Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. , 2007, International journal of radiation oncology, biology, physics.

[104]  S. Vergez,et al.  Brachytherapy in lip carcinoma: long-term results. , 2011, International journal of radiation oncology, biology, physics.

[105]  H. Bartelink,et al.  The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[106]  K. Tai,et al.  Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[107]  L. Incrocci,et al.  Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[108]  C. Haie-meder,et al.  Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. , 2011, International journal of radiation oncology, biology, physics.

[109]  E. van Limbergen,et al.  Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[110]  Vythialingam Sathiaseelan,et al.  Intra-operative pubic arch interference during prostate seed brachytherapy in patients with CT-based pubic arch interference of < or =1cm. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[111]  Y. Yoshioka,et al.  Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. , 2011, International journal of radiation oncology, biology, physics.

[112]  J. Dimopoulos,et al.  Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. , 2007, International journal of radiation oncology, biology, physics.

[113]  Shaleen Kumar,et al.  A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[114]  Christine Haie-Meder,et al.  DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[115]  P. Novaes,et al.  The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition , 2008, International journal of medical sciences.

[116]  C. Lawton Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) , 2011 .

[117]  G. Németh,et al.  Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[118]  K. Johansson,et al.  Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[119]  Marco Zaider,et al.  Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[120]  Kari Tanderup,et al.  Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[121]  Christian Kirisits,et al.  The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. , 2006, International journal of radiation oncology, biology, physics.

[122]  Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[123]  J. Dimopoulos,et al.  Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. , 2011, International journal of radiation oncology, biology, physics.

[124]  C. Kirisits,et al.  PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[125]  F. Foroudi,et al.  Urethral stricture following high dose rate brachytherapy for prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[126]  C. Kirisits,et al.  Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy. , 2008, Brachytherapy.

[127]  N. Schalij-Delfos,et al.  Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[128]  Christian Kirisits,et al.  Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. , 2007, International journal of radiation oncology, biology, physics.

[129]  C. Marijnen External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[130]  D. Baltas,et al.  3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer , 2004, Strahlentherapie und Onkologie.

[131]  Kailash Narayan,et al.  Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. , 2009, International journal of radiation oncology, biology, physics.

[132]  I. Trop,et al.  Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[133]  P. Grigsby,et al.  Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders. , 2010, International journal of radiation oncology, biology, physics.

[134]  M. Halliwell,et al.  Magnetic resonance imaging appearances in the postoperative breast: the clinical target volume-tumor and its relationship to the chest wall. , 2008, International journal of radiation oncology, biology, physics.

[135]  Y. Yamada,et al.  Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. , 2008, Brachytherapy.

[136]  J. Earle,et al.  Chapter 38 – Brachytherapy for Choroidal Melanoma , 2006 .

[137]  J. Battermann,et al.  Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[138]  Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[139]  J. Bonneterre,et al.  Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[140]  J. Dimopoulos,et al.  Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. , 2007, International journal of radiation oncology, biology, physics.

[141]  P. Hoskin,et al.  Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[142]  M. Bani,et al.  Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. , 2011, International journal of radiation oncology, biology, physics.

[143]  Hyun-Cheol Kang,et al.  3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[144]  M. Kattan,et al.  Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. , 2009, International journal of radiation oncology, biology, physics.

[145]  B. Slotman,et al.  Patterns of care study for brachytherapy: results of the questionnaire for the years 2002 and 2007 in The Netherlands , 2010, Journal of contemporary brachytherapy.

[146]  J. Deneufbourg,et al.  192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[147]  R. Laing,et al.  Novel prostate brachytherapy technique: improved dosimetric and clinical outcome. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[148]  Inger-Karine K Kolkman-Deurloo,et al.  Three-dimensional dose addition of external beam radiotherapy and brachytherapy for oropharyngeal patients using nonrigid registration. , 2011, International journal of radiation oncology, biology, physics.

[149]  J. Mazeron,et al.  Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer--a twenty three year experience. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[150]  H. Putter,et al.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.

[151]  C. Rentsch,et al.  Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[152]  A. Chicheł,et al.  HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer--comparison of two different dose schedules. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[153]  Marinus A Moerland,et al.  Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[154]  E. van der Schueren,et al.  Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. , 1989 .

[155]  J. Wildberger,et al.  Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: experiments and a simulation model. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[156]  R. Nout,et al.  The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends , 2011, Current oncology reports.

[157]  Christian Kirisits,et al.  Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[158]  Kari Tanderup,et al.  Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[159]  J. Langendijk,et al.  External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[160]  P. Hoskin,et al.  High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[161]  Phantom investigations on CT seed imaging for interstitial brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[162]  Christian Kirisits,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[163]  C. Haie-meder,et al.  MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[164]  G. Németh,et al.  Radiotherapy Confined to the Tumor Bed Following Breast Conserving Surgery , 2002, Strahlentherapie und Onkologie.

[165]  E van der Schueren,et al.  Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[166]  Richard Pötter,et al.  Patterns of care for brachytherapy in Europe: updated results. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[167]  J. Blasko,et al.  Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. , 2011, International journal of radiation oncology, biology, physics.

[168]  E. Briot,et al.  The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. , 1990, International journal of radiation oncology, biology, physics.

[169]  G. Németh,et al.  Electron and High-Dose-Rate Brachytherapy Boost in the Conservative Treatment of Stage I–II Breast Cancer , 2002, Strahlentherapie und Onkologie.

[170]  R. Keenan,et al.  Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy. , 2011, International journal of radiation oncology, biology, physics.

[171]  R. Cormack,et al.  Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields , 2008, Radiation oncology.

[172]  Alex Rijnders,et al.  Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[173]  J. Dimopoulos,et al.  Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[174]  J. Yarnold,et al.  Accelerated partial breast irradiation trials: diversity in rationale and design. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[175]  J. Delaloye,et al.  Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer: A Controlled Randomized Study , 2009, International Journal of Gynecologic Cancer.

[176]  J. Logue,et al.  Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[177]  C. Haie-meder,et al.  Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. , 2007, International journal of radiation oncology, biology, physics.

[178]  Holger Borchers,et al.  Low-dose rate brachytherapy for men with localized prostate cancer. , 2011, The Cochrane database of systematic reviews.

[179]  T. Major,et al.  Dosimetric characteristics of accelerated partial breast irradiation with CT image--based multicatheter interstitial brachytherapy: a single institution's experience. , 2011, Brachytherapy.

[180]  Jan J W Lagendijk,et al.  Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[181]  Christian Kirisits,et al.  Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[182]  Thorsten Schneider,et al.  Realisation of the absorbed dose to water for I-125 interstitial brachytherapy sources. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[183]  M. Eble,et al.  Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[184]  J. Mazeron Brachytherapy: a new era. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[185]  C. Haie-meder,et al.  Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[186]  Christian Kirisits,et al.  Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[187]  R. Laing,et al.  The value of Day 1 imaging following LDR prostate brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[188]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .

[189]  Y. Niibe,et al.  Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[190]  Martin Bues,et al.  Effect of random seed placement error in permanent transperineal prostate seed implant. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[191]  J. Dimopoulos,et al.  Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. , 2012, International journal of radiation oncology, biology, physics.

[192]  Yvette Seppenwoolde,et al.  HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[193]  R. Pötter,et al.  Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[194]  Christian Kirisits,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[195]  R. Pötter,et al.  Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[196]  R. Fietkau,et al.  Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[197]  Christian Kirisits,et al.  Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[198]  A. Courdi,et al.  Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction. , 2011, Brachytherapy.

[199]  Louis Potters,et al.  Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. , 2007, International journal of radiation oncology, biology, physics.

[200]  Gerry Lowe,et al.  Applicator reconstruction for HDR cervix treatment planning using images from 0.35 T open MR scanner. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[201]  T. Mate,et al.  Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[202]  J. Crook,et al.  Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[203]  Christian Kirisits,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[204]  Marinus A Moerland,et al.  Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[205]  Richard Pötter,et al.  Image-guided brachytherapy sets benchmarks in advanced radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[206]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[207]  Bradley R Pieters,et al.  Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[208]  Peter Bownes,et al.  High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[209]  H. Hoshi,et al.  MRI-Based Preplanning in Low-Dose-Rate Prostate Brachytherapy , 2007 .

[210]  Steven J Frank,et al.  Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. , 2010, International journal of radiation oncology, biology, physics.

[211]  E. M. Pedersen,et al.  Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[212]  M. Moerland,et al.  The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[213]  J. Persliden,et al.  Phantom study of radiation doses outside the target volume brachytherapy versus external radiotherapy of early breast cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[214]  Kari Tanderup,et al.  From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[215]  H. Ackermann,et al.  Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[216]  Kari Tanderup,et al.  MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. , 2008, International journal of radiation oncology, biology, physics.

[217]  W. J. Morris,et al.  Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[218]  Robert A Cormack,et al.  Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[219]  A. Hart,et al.  A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[220]  K. Wallner,et al.  Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[221]  H. Andersson,et al.  External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study. , 2012, International journal of radiation oncology, biology, physics.

[222]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[223]  P. Georg,et al.  The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[224]  E van der Schueren,et al.  Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[225]  J. Battermann,et al.  Measurement of prostate rotation during insertion of needles for brachytherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[226]  Lonneke V van de Poll-Franse,et al.  Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[227]  Christian Kirisits,et al.  Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[228]  P. Grigsby,et al.  The irradiation tolerance dose of the proximal vagina. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[229]  F. Vicini,et al.  The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast. , 1997, International journal of radiation oncology, biology, physics.

[230]  T. Major,et al.  Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[231]  J. Dimopoulos,et al.  Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[232]  Y. Yamada,et al.  American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. , 2011, Brachytherapy.

[233]  P. Hoskin,et al.  Prostate brachytherapy in Europe: growth, practice and guidelines. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[234]  Marinus A Moerland,et al.  Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[235]  E. M. Pedersen,et al.  Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer , 2010, Acta oncologica.

[236]  U. Grouven,et al.  Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. , 2011, European urology.